Showing posts with label dose to the tumor journals. Show all posts
Showing posts with label dose to the tumor journals. Show all posts

Thursday, 12 January 2017

Development of Thulium-170 Brachytherapy Sources and Application in Rats Treatment

Experimental work where Tm-170 LDR seeds and one HDR source were used to treat cancer on rats is described. Experiments were done with Lewis rats, carrying tumor developed from implantation of CNS-1 Rat Brain Tumor Astrocytoma cells, under the thigh skin. 75% of both HDR and LDR treated rats were completely cured.

Rats Treatment
I-125 seeds experiments were done as a control, only 8.3% were cured with a similar photon dose. The dose due to beta radiation is very significant and was the main reason for the treatment success.

Tm-170 seeds and a source were developed and tested for brachytherapy. The two common brachytherapy methods were used in the present work; permanent implantation, or low dose rate, LDR, where low activity seeds are implanted and remain inside the tumor, and temporary implantation of a high dose rate (HDR) source, where a high activity source stays inside the tumor for a short time and then removed